pegbelfermin

Third-quarter events to watch for large drug makers
EP Vantage
Mon, 06/22/20 - 10:35 am
Biogen
aducanumab
Sanofi
THOR-707
Bristol-Myers Squibb
pegbelfermin
Eli Lilly
FDA